7-nitroindazole has been researched along with Hyperprolactinemia in 1 studies
7-nitroindazole: an inhibitor of nitric oxide synthase; exhibits anti-nociceptive activity without increasing blood pressure
Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vega, C | 1 |
| Moreno-Carranza, B | 1 |
| Zamorano, M | 1 |
| Quintanar-Stéphano, A | 1 |
| Méndez, I | 1 |
| Thebault, S | 1 |
| Martínez de la Escalera, G | 1 |
| Clapp, C | 1 |
1 other study available for 7-nitroindazole and Hyperprolactinemia
| Article | Year |
|---|---|
Prolactin promotes oxytocin and vasopressin release by activating neuronal nitric oxide synthase in the supraoptic and paraventricular nuclei.
Topics: Animals; Enzyme Inhibitors; Hyperprolactinemia; Indazoles; Injections, Intraventricular; Male; Neuro | 2010 |